INTERNATIONAL PATENT: SHANGHAI HUILUN PHARMACEUTICAL CO., LTD., 上海汇伦医药股份有限公司 FILES APPLICATION FOR "NOVEL USE OF N-[2-[[[4-(2,2-DIMETHYL-1-OXOPROPOXY)PHENYL]SULFONYL]AMINO]BENZOYL]-(S)-GLYCINE OR SALT THEREOF"

GENEVA, July 14 -- SHANGHAI HUILUN PHARMACEUTICAL CO., LTD. (10th Floor, Building 5, No. 525 Yuanjiang RoadMinhang District, Shanghai 200241), 上海汇伦医药股份有限公司 (中国上海市闵行区元江路525号5幢10层) filed a patent application (PCT/CN2025/076621) for "NOVEL USE OF N-[2-[[[4-(2,2-DIMETHYL-1-OXOPROPOXY)PHENYL]SULFONYL]AMINO]BENZOYL]-(S)-GLYCINE OR SALT THEREOF" on Feb 10, 2025. With publication no. WO/2025/146212, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IP...